Fri.Feb 07, 2025

article thumbnail

Majority of People Support Pharmacist Prescribed Hormonal Contraceptives

Drug Topics

Investigators from the University of Rhode Island College of Pharmacy discuss 2 studies that assessed perspectives on pharmacist prescribed hormonal contraceptives.

98
article thumbnail

Video: GLP-1 Medications Revolutionize Obesity and Diabetes Care, With Exciting Advances on Horizon

Pharmacy Times

Donna Ryan discusses the landscape of GLP-1 medications and the lineup of indications that the drug class has received indications for in recent years.

81
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Mirikizumab Demonstrates Sustained Clinical, Endoscopic Outcomes for Crohn Disease

Drug Topics

Patients who achieved clinical remission at 1 year in VIVID-1 maintain clinical remission at 92.9% at 2 years with the Crohn Disease Activity Index.

98
article thumbnail

Study Finds Fasting Plasma Glucose Level Is Associated With Development of Diabetes

Pharmacy Times

Age, body mass index, and male sex are also associated with the development of diabetes.

65
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

APhA Platform Aims to Tackle Pharmacy Workforce Shortage

Drug Topics

The American Pharmacists Association announced the launch of its transformative HealthShifts platform in collaboration with the California Pharmacists Association and powered by Locumate.

98
article thumbnail

Pharmacists Can Stay Aware of the Evolving Landscape of Gout Treatment to Address Unmet Needs

Pharmacy Times

New therapies are being developed for individuals with gout.

65

More Trending

article thumbnail

Risk Scores Using Molecular Data Can Better Identify Patients With Primary Myelofibrosis Who Benefit From HSCT

Pharmacy Times

More accurate prognostic risk assessment could aid pharmacists in the management and counseling of patients with primary myelofibrosis.

65
article thumbnail

Rabies srRNA Vaccine Demonstrates Robust Immune Response

Drug Topics

RBI-4000 is a self-replicating RNA (srRNA) vaccine developed to stimulate virus-neutralizing immune responses to rabies for prophylactic use.

76
article thumbnail

FDA Grants Fast Track Designation to ADI-001 for Treatment of Refractory Systemic Lupus Erythematosus

Pharmacy Times

The designation builds on previous regulatory action for ADI-001 and allows for expedited development of the treatment for systemic lupus erythematosus.

FDA 65
article thumbnail

Many Americans Trust Health Care Providers, Scientific Researchers

Drug Topics

The survey results show 1 in 4 Americans ranked health care access and affordability as their highest public health priority for government officials to address.

76
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Signs of life at the CDC

STAT

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. Good morning.

60
article thumbnail

Bain Capital buys Mitsubishi Tanabe Pharma for $3.3bn

Pharmaceutical Technology

Bain Capital said its decision to buy Mitsubishi Tanabe is due to the strong growth potential of Japans healthcare industry.

59
article thumbnail

Bain buys Japanese pharma Mitsubishi Tanabe for $3.4bn

pharmaphorum

Bain Capital has agreed to buy Mitsubishi Tanabe for around $3.

59
article thumbnail

Sanofi increases ownership stake partaking in pharma buyback trend

Pharmaceutical Technology

Sanofi has agreed to purchase its own shares worth 2bn ($2.08bn), part of a $5.1bn share buyback initiative in 2025.

59
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

FDA starts review of first bronchiectasis drug candidate

pharmaphorum

The FDA has started a priority review of Insmed's brensocatib, which is pitching to become the first approved therapy for bronchiectasis in the US.

FDA 59
article thumbnail

Alumis and Acelyrin sign merger agreement

Pharmaceutical Technology

Alumis and Acelyrin have announced a definitive merger agreement, which will result in an all-stock transaction.

59
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Two startups that aim to make it easier for consumers to connect with dietitians and nutrition counseling each raised $50 million as demand grows for metabolic health solutions.

52
article thumbnail

Genentech eyes lupus market for Gazyva with positive Phase III data readout  

Pharmaceutical Technology

Genentech has shared positive data from the Phase III REGENCY trial with regulators in the US and EU.

59
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Breaking Point: How 2025 Will Reshape Patient Support Services

Pharmaceutical Commerce

From matrix programs to anti-abandonment strategies, predictions for a new era.

52
article thumbnail

Dr Reddy’s and Shanghai Henlius sign agreement for HLX15

Pharmaceutical Technology

Dr Reddy's Laboratories has signed a licence agreement with Shanghai Henlius Biotech to develop and commercialise HLX15.

59
article thumbnail

FDA Approves Supernus Pharmaceuticals’ Onapgo for Managing Motor Fluctuations in Parkinson Disease

PharmExec

Approval of Onapgo (apomorphine hydrochloride) marks the first and only subcutaneous apomorphine infusion device for managing motor fluctuations in adults with advanced Parkinson disease.

52
article thumbnail

Treating alcohol addiction: filling the medication gap

Pharmaceutical Technology

With Dry January firmly behind us, many adults are prompted to reassess their relationship with alcohol. Alcohol Change, the UK charity behind the popular Dry January initiative, found that 30% of men and 26% of women in the UK wished to reduce the amount of alcohol they drank in 2024.

59
article thumbnail

JP Morgan Week 2025 – Phil Johnson

pharmaphorum

Stay tuned for an exclusive video interview with Phil Johnson from JP Morgan Week 2025, where he shares insights and perspectives on the future of finance and technology.

52
article thumbnail

Relmada acquires Tourette’s therapy rights from Asarina

Pharmaceutical Technology

Relmada has acquired complete ownership rights to Sepranolone, developed for Tourette syndrome (TS) from Asarina Pharma.

59
article thumbnail

Bridging to the PhD

Blog: Ask a Student Pharmacist

Bridging to the PhD ceele001 Fri, 02/07/2025 - 09:37 Bridging to the PhD Occupational therapy doctoral students may be eligible to Rehabilitation Science Graduate Program to bridge into earning a PhD in Rehabilitation Science from Rehabilitation Science Graduate Program in the Us Medical School. Mission The mission of the Rehabilitation Science Graduate Program is to discover and disseminate rehabilitation knowledge and improve the quality of life, participation, health, performance and well-bei

article thumbnail

How AI is streamlining cell and gene therapy manufacturing

Pharmaceutical Technology

AI could deliver substantially greater efficiencies in cell and gene therapy manufacturing and enable more patients to benefit.

59
article thumbnail

M&A in Pharma: Balancing Growth and Risk

Pharmaceutical Commerce

What factors should be consideredand how can both parties benefit long-term?

52
article thumbnail

Pfizer Appoints Jeffrey Legos as Chief Oncology Officer

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52
article thumbnail

Investigating the Unwinding of Continuous Medicaid Coverage During the COVID-19 Pandemic

Pharmaceutical Commerce

A cohort study investigates the magnitude of lost coverage among pediatric patients, following the conclusion of the pandemic public health emergency.

52
article thumbnail

Do mirtazapine and alcohol mix?

The Checkup by Singlecare

Mirtazapine is a prescription medication approved to treat depression, and is particularly helpful for improving sleep and overall mood. Though this medication can be effective, some who take it might find themselves at a dinner party, a night out with friends, or another situation that involves alcohol. However, mixing mirtazapine and alcohol is not recommended due to potential health risks and increased side effects, like drowsiness and dizziness.

Dosage 52
article thumbnail

Welcome to the 'Dark Side'

Pharmaceutical Commerce

Introducing a new Pharma Commerce column focused on combating illicit trade and protecting product integrityand ultimately patients.

52
article thumbnail

Bristol Myers gives first peek at closely watched launch of schizophrenia drug

PharmaVoice

Cobenfy, the main asset acquired through Bristol Myers’ $14 billion purchase of Karuna, had $10 million in sales in the fourth quarter and around 1,000 prescriptions weekly by late January.

52
article thumbnail

MSD starts pivotal trial of ROR1 drug in first-line lymphoma

pharmaphorum

MSD has started a phase 3 trial of ROR1-directed ADC zilo-V as a treatment for previously untreated diffuse large B-cell lymphoma.

52